CO5700769A2 - Composicion farmaceutica de liberacion prolongada - Google Patents

Composicion farmaceutica de liberacion prolongada

Info

Publication number
CO5700769A2
CO5700769A2 CO05049742A CO05049742A CO5700769A2 CO 5700769 A2 CO5700769 A2 CO 5700769A2 CO 05049742 A CO05049742 A CO 05049742A CO 05049742 A CO05049742 A CO 05049742A CO 5700769 A2 CO5700769 A2 CO 5700769A2
Authority
CO
Colombia
Prior art keywords
composition according
cefquinone
weight
pharmaceutical composition
oil
Prior art date
Application number
CO05049742A
Other languages
English (en)
Spanish (es)
Inventor
Peter Schmidt
Alexander Boettner
Carsten Schmidt
Mark Allan
Carole Barbot
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of CO5700769A2 publication Critical patent/CO5700769A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CO05049742A 2002-10-25 2005-05-23 Composicion farmaceutica de liberacion prolongada CO5700769A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02079477 2002-10-25

Publications (1)

Publication Number Publication Date
CO5700769A2 true CO5700769A2 (es) 2006-11-30

Family

ID=32116298

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05049742A CO5700769A2 (es) 2002-10-25 2005-05-23 Composicion farmaceutica de liberacion prolongada

Country Status (18)

Country Link
EP (1) EP1558263B1 (https=)
JP (1) JP4584715B2 (https=)
CN (1) CN1326526C (https=)
AR (1) AR041713A1 (https=)
AT (1) ATE327759T1 (https=)
AU (1) AU2003279302B2 (https=)
BR (2) BRPI0315513B1 (https=)
CA (1) CA2501395C (https=)
CO (1) CO5700769A2 (https=)
DE (1) DE60305728T2 (https=)
ES (1) ES2265590T3 (https=)
MX (1) MXPA05004219A (https=)
NO (1) NO334158B1 (https=)
NZ (1) NZ539478A (https=)
PL (1) PL208585B1 (https=)
PT (1) PT1558263E (https=)
WO (1) WO2004037265A1 (https=)
ZA (1) ZA200502956B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2661099C (en) * 2006-08-30 2012-01-24 Intervet International B.V. Pharmaceutical compositions comprising cefquinome
AU2007234612B2 (en) 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
CN101801405A (zh) 2007-08-07 2010-08-11 先进科技及再生医学有限责任公司 包含于酸性水溶液中的gdf-5的蛋白质配方
BRPI0911048A2 (pt) 2008-04-14 2015-12-29 Atrm Llc formulações líquidas tamponadas de gdf-5
TWI400243B (zh) * 2009-07-20 2013-07-01 Intervet Int Bv 製造西喹諾（ｃｅｆｑｕｉｎｏｍｅ）粒子的方法
WO2012095438A1 (en) * 2011-01-12 2012-07-19 Intervet International B.V. Particles and suspensions of cephalosporin antibiotics
AU2012206621B2 (en) * 2011-01-12 2017-04-27 Intervet International B.V. Use of liquid medium exchange by cross flow filtration in the preparation of drug suspensions
CN102319210B (zh) * 2011-09-29 2013-05-01 武汉回盛生物科技有限公司 一种兽用长效硫酸头孢喹肟注射液及其制备方法
CN104546703B (zh) * 2013-12-10 2017-06-23 中国农业科学院饲料研究所 一种奶牛泌乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN104000783B (zh) * 2014-05-14 2017-12-05 河南牧翔动物药业有限公司 头孢喹肟脂质体
CN104873462B (zh) * 2014-11-18 2017-04-05 中国农业科学院饲料研究所 一种奶牛干乳期用硫酸头孢喹肟乳房注入剂及其制备方法
CN107157927A (zh) * 2017-05-31 2017-09-15 合肥中龙神力动物药业有限公司 动物用硫酸头孢喹肟注射液及其制备方法
CN109044970A (zh) * 2018-11-08 2018-12-21 遂宁市中通实业集团动物药业有限公司 一种硫酸头孢喹肟注射液及其制备方法
CN113209014A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效硫酸头孢喹肟混悬注射液及其制备工艺
CN113952298B (zh) * 2021-12-08 2023-02-17 江苏农牧科技职业学院 硫酸头孢喹肟纳米混悬液及其制备方法
CN117281796A (zh) * 2023-09-27 2023-12-26 中牧全药(南京)动物药品有限公司 一种治疗奶牛乳房炎的硫酸头孢喹肟缓释制剂及其制备方法
CN117982413B (zh) * 2024-04-03 2024-06-18 山东恒邦中科生物工程有限公司 一种硫酸头孢喹肟注射液的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920819A (en) * 1974-12-02 1975-11-18 Lilly Co Eli Nonaqueous vehicle for oral pharmaceutical suspensions
IE49768B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
IE51846B1 (en) * 1980-11-17 1987-04-15 Leo Pharm Prod Ltd Pharmaceutical preparation for veterinary use and an appliance containing it
GB8531609D0 (en) * 1985-12-23 1986-02-05 Beecham Group Plc Compounds
JP3022692B2 (ja) * 1992-10-13 2000-03-21 三菱マテリアル株式会社 リーク検査装置
GB9306106D0 (en) * 1993-03-24 1993-05-12 Norbrook Lab Ltd Sustained release veterinary composition
DE4440141A1 (de) * 1994-11-10 1996-05-15 Hoechst Ag Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung
GB9907916D0 (en) * 1999-04-07 1999-06-02 Takeda Chemical Industries Ltd Long-acting antibacterial composition
WO2003063877A1 (en) * 2002-02-01 2003-08-07 Akzo Nobel N.V. Cefquinome composition for intra-mammary administration in cattle

Also Published As

Publication number Publication date
ES2265590T3 (es) 2007-02-16
EP1558263B1 (en) 2006-05-31
AU2003279302B2 (en) 2008-10-16
JP4584715B2 (ja) 2010-11-24
BR0315513A (pt) 2005-08-23
PT1558263E (pt) 2006-10-31
WO2004037265A1 (en) 2004-05-06
DE60305728T2 (de) 2006-10-12
MXPA05004219A (es) 2005-06-08
CA2501395C (en) 2011-05-24
AU2003279302A1 (en) 2004-05-13
PL208585B1 (pl) 2011-05-31
NZ539478A (en) 2006-05-26
CA2501395A1 (en) 2004-05-06
AR041713A1 (es) 2005-05-26
JP2006510607A (ja) 2006-03-30
ATE327759T1 (de) 2006-06-15
ZA200502956B (en) 2006-03-29
NO20051654L (no) 2005-05-24
CN1326526C (zh) 2007-07-18
BRPI0315513B1 (pt) 2017-11-28
DE60305728D1 (de) 2006-07-06
NO334158B1 (no) 2013-12-23
PL376840A1 (pl) 2006-01-09
CN1705483A (zh) 2005-12-07
EP1558263A1 (en) 2005-08-03

Similar Documents

Publication Publication Date Title
CO5700769A2 (es) Composicion farmaceutica de liberacion prolongada
AR051421A1 (es) Composiciones de aceites ricos en acidos grasos poliinsaturados (pufa)
CL2007003447A1 (es) Composicion lubricante que comprende un aceite base, fosfato tricalcico en concentraciones de 2 a 68% en peso relativo a la composicion total y un agente tensioactivo; y uso de dicah composicion.
ATE469641T1 (de) Pharmazeutische formulierung mit statinmikrokapseln in alkylestern mehrfach ungesättigter fettsäuren
AR054444A2 (es) Mezcla en forma solida de rapamicina o un derivado se rapamicina y un antioxidante
BRPI0410184A (pt) partìculas de matriz de alginato
ATE324410T1 (de) Laserbeschriftbare formmassen
AR030891A1 (es) Un metodo para suprimir el mal olor bucal y proporcionar proteccion de larga duracion contra el mal aliento en la cavidad oral
CR7999A (es) Metodos y composiciones farmaceuticas para la obtencion confiable de niveles aceptables de testosterona en suero
AR028703A1 (es) Aceites para el cabello
MXPA06011984A (es) Uso de (met) acrilatos de polialquilo en composiciones de aceite lubricante.
ES2183407T3 (es) Composicion polimera de mecha para un producto de vela ambientadora.
JP2004503480A5 (https=)
CO5650217A2 (es) Composicion oral estable, antiplaca, que comprende un compuesto ester antibacteriano derivado de arginina
BRPI0413491A (pt) sistema de gordura vegetal hidrogenada
CL2003002356A1 (es) Compuestos derivados de 1-(1-acetil-piperidin-4-il)-(ester o amida)-4-(bencidrilo sustituido)-2-tert-butil-piperazina, composicion farmaceutica, y su uso en la inhibicion de 17b-hidroxiesteroide deshidrogenasa de tipo 3 y de enfermedades que dependen
EA200800148A1 (ru) Применение фуллерена с60 в качестве стабилизатора масел
AR045911A1 (es) Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administracion oral de taxoides
AR110045A2 (es) Composiciones farmacéuticas
AR044862A1 (es) Composiciones para la higiene oral que presentan propiedades antiplaca y refrescantes del aliento
BR0009738A (pt) Fluido hidráulico, e, pacote de aditivo para preparar um fluido hidráulico
AR058527A1 (es) Composicion de aceite lubricante
BR0103014A (pt) Composição de fragância que compreende uma mistura de nitrilas
AR060249A1 (es) Composiciones de pintura solidas mejoradas
DE602005022206D1 (de) Parfumbestandteile mit safrangeruch

Legal Events

Date Code Title Description
FD Application lapsed